Swissmedic authorises COVID-19 Vaccine Moderna for use in Switzerland

Moderna

12 January 2021 - Swiss Federal Government has secured 7.5 million doses and first deliveries expected to begin in January.

Moderna today announced that Swissmedic has authorized the COVID-19 Moderna Vaccine in Switzerland.

The authorisation is given according to the ordinary approvals procedure and is based on a rolling submission of data and the totality of scientific evidence shared by the Company, including a data analysis from the pivotal Phase 3 clinical study announced on November 30.

Read Moderna press release

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Outcome , Vaccine , Switzerland , COVID-19